BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 32333965)

  • 1. Dichotomy of complement system: Tumorigenesis or destruction.
    Sinha A; Singh V; Tandon R; Mohan Srivastava L
    Immunol Lett; 2020 Jul; 223():89-96. PubMed ID: 32333965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement as a Biological Tool to Control Tumor Growth.
    Macor P; Capolla S; Tedesco F
    Front Immunol; 2018; 9():2203. PubMed ID: 30319647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent progress in the understanding of complement activation and its role in tumor growth and anti-tumor therapy.
    Liu XY; Wang XY; Li RY; Jia SC; Sun P; Zhao M; Fang C
    Biomed Pharmacother; 2017 Jul; 91():446-456. PubMed ID: 28477461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxic mechanisms of immunotherapy: Harnessing complement in the action of anti-tumor monoclonal antibodies.
    Taylor RP; Lindorfer MA
    Semin Immunol; 2016 Jun; 28(3):309-16. PubMed ID: 27009480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting complement-mediated immunoregulation for cancer immunotherapy.
    Kolev M; Markiewski MM
    Semin Immunol; 2018 Jun; 37():85-97. PubMed ID: 29454575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dual role of complement in cancers, from destroying tumors to promoting tumor development.
    Lu P; Ma Y; Wei S; Liang X
    Cytokine; 2021 Jul; 143():155522. PubMed ID: 33849765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement as effector system in cancer immunotherapy.
    Macor P; Tedesco F
    Immunol Lett; 2007 Jul; 111(1):6-13. PubMed ID: 17572509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Membrane Bound Complement Regulatory Proteins in Tumor Development and Cancer Immunotherapy.
    Geller A; Yan J
    Front Immunol; 2019; 10():1074. PubMed ID: 31164885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement inhibition in cancer therapy.
    Pio R; Ajona D; Lambris JD
    Semin Immunol; 2013 Feb; 25(1):54-64. PubMed ID: 23706991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The complement system in cancer: Ambivalence between tumour destruction and promotion.
    Mamidi S; Höne S; Kirschfink M
    Immunobiology; 2017 Jan; 222(1):45-54. PubMed ID: 26686908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How Does Complement Affect Hematological Malignancies: From Basic Mechanisms to Clinical Application.
    Luo S; Wang M; Wang H; Hu D; Zipfel PF; Hu Y
    Front Immunol; 2020; 11():593610. PubMed ID: 33193442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting innate immune pathways in cancer immunotherapy: state of the art.
    Mastellos DC
    J BUON; 2009 Sep; 14 Suppl 1():S123-30. PubMed ID: 19785054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Back to the future - non-canonical functions of complement.
    Kemper C; Köhl J
    Semin Immunol; 2018 Jun; 37():1-3. PubMed ID: 29857931
    [No Abstract]   [Full Text] [Related]  

  • 14. Cancer and the complement cascade.
    Rutkowski MJ; Sughrue ME; Kane AJ; Mills SA; Parsa AT
    Mol Cancer Res; 2010 Nov; 8(11):1453-65. PubMed ID: 20870736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic Lessons to be Learned From the Role of Complement Regulators as Double-Edged Sword in Health and Disease.
    de Boer ECW; van Mourik AG; Jongerius I
    Front Immunol; 2020; 11():578069. PubMed ID: 33362763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor immunology.
    Naftzger C; Houghton AN
    Curr Opin Oncol; 1991 Feb; 3(1):93-9. PubMed ID: 2043699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of complement in tumor growth.
    Pio R; Corrales L; Lambris JD
    Adv Exp Med Biol; 2014; 772():229-62. PubMed ID: 24272362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drivers and regulators of humoral innate immune responses to infection and cancer.
    Kumar D; Romero Y; Schuck KN; Smalley H; Subedi B; Fleming SD
    Mol Immunol; 2020 May; 121():99-110. PubMed ID: 32199212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibiting complement regulators in cancer immunotherapy with bispecific mAbs.
    Gelderman KA; Lam S; Gorter A
    Expert Opin Biol Ther; 2005 Dec; 5(12):1593-601. PubMed ID: 16318423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement in Metastasis: A Comp in the Camp.
    Ajona D; Ortiz-Espinosa S; Pio R; Lecanda F
    Front Immunol; 2019; 10():669. PubMed ID: 31001273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.